News ArchivesRead News
University of Kentucky Researchers Announce Experimental Treatment for Parkinson's Patients
Monday November 18, 2013
Kentucky Herald-Leader - Someday soon, a patient who receives a Parkinson's diagnosis might be able to stop or even reverse the disease's spread with a transplant of nerve tissue from his or her own body.
University of Kentucky physicians are working on a pilot program in which Parkinson's patients who have deep-brain stimulation surgery — in which a device like a pacemaker regulates nerve cues in the brain — are also having nerve tissue grafted into their brain that was taken from near their ankles.
UK is the first medical center in the United States to conduct the clinical trial.
Five people have joined the program, and Dr. Craig van Horne, UK assistant professor of neurosurgery and principle investigator of the clinical trial, called their progress encouraging.
"I've been refining this idea for decades," said van Horne, who has been at UK for two years. "It allows us to take the next step, see what works, see what doesn't work."
The process might not be a home run — his eventual goal is to find a way to restore function of the brain's damaged cells, allowing a patient's symptoms to stabilize or reverse — but it should yield enough information for UK to continue research, he said.
Parkinson's affects about 1 million Americans, and 10 million people worldwide, according to UK. It is a progressive and degenerative disease in which the death of nerves deep in the brain causes an array of motor and non motor symptoms, and there is no known cure. Parkinson's symptoms include tremor, rigidity, slow movement and unstable posture.
Whether the process is a significant move ahead in Parkinson's treatment probably will be known in a year or so, van Horne said. In the meantime, the project is seeking more participants. Those selected have to be candidates for deep-brain stimulation surgery and willing to have the additional nerve tissue transplant.
The peripheral nerves, unlike those in the brain and spinal cord, can regenerate when they are damaged. The hope is that the implanted nerve tissue will release chemicals that will help the brain heal itself by stimulating regeneration in the parts of the brain damaged by Parkinson's.
Deep-brain stimulation surgery has been used for more than 10 years to help patients with Parkinson's. It alleviates some of the movement problems suffered by Parkinson's patients, but it doesn't halt the progress of the disease. The cruelty of Parkinson's is that by the time it's detected, much of the degeneration it will cause in the brain is well underway.
Rodney Parsons, 71, of Lexington has had Parkinson's for 10 years. He went to doctors around the country before finding van Horne at UK. He isn't part of the trial, but he underwent deep brain stimulation surgery and has nothing but praise for van Horne's skills and research abilities.
Parsons first noticed a tremor in his right hand, then his left. Then he developed a slumped posture. After the deep-brain stimulation surgery, Parsons felt better immediately.
On Monday, he commended van Horne's skills as a person and a surgeon.
"He's very humble and very easy to talk to," Parsons said.
Truman, C. (18 Nov. 2013). Kentucky Herald-Leader. University of Kentucky researchers announce experimental treatment for Parkinson's patients. www.kentucky.com.
Recent NewsOct 18 - Brain disconnections may contribute to Parkinson's hallucinations
Oct 18 - Fighting Parkinson's disease through dance
Oct 17 - Scientists Identify Structure of PINK1, Key Parkinson’s-protective Protein
Oct 17 - Diabetes drug cuts Parkinson's risk by 28 percent, study finds
Oct 10 - Advances in Brain Pacemaker Reduces Tremors, Helps Parkinson's Sufferers Live a More Normal Life
Oct 10 - Medical History Could Help Predict Parkinson's Disease Risk Long Before Diagnosis
Oct 3 - Changes in Olfactory Bulb Explain Loss of Smell in Early Stages of Parkinson’s Disease, Study Finds
Oct 3 - Sleep Disturbances May Worsen Motor Symptoms in Parkinson’s Disease, Study Suggests
Sep 12 - Australian Researchers Develop New Diagnostic Tool to Spot Early Signs of Parkinson’s
Sep 11 - GeneFo Webinar to Focus on Using Humor to Manage Parkinson’s Disease
Sep 6 - Parkinson’s and the ‘D’ word
Sep 6 - Compounds in Asthma Drugs Might Be Used as Parkinson’s Treatment
Sep 5 - AstraZeneca Joins Takeda, Berg to Advance Development of Parkinson’s Disease Therapies
Sep 1 - Stem Cell Transplant Trial in Parkinson’s Patients Planned After Test in Japan Succeeds in Monkeys
Sep 1 - Titan to Start Phase 1/2 Study of Subdermal Implant to Deliver Requip to Parkinson’s Patients
Aug 30 - FDA Refuses Acorda’s Inbrija New Drug Application Due to Manufacturing Questions
Aug 23 - Support Groups: Are They for You?
Aug 22 - Internet Visits with Parkinson’s Specialist Can Be as Effective as In-person Visits, Trial Finds
Aug 21 - Cavion’s New CMO to Lead Cav3 Platform Development for Neurological Diseases
Aug 15 - Singing Helps Early-stage Parkinson’s Patients Retain Speech, Respiratory Control, Studies Show